Method and application for efficiently constructing large-fragment deletion mutants of genome
By using the CRISPR system and optimized gRNA combinatorial microinjection technology in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters, the efficiency of genome large fragment deletion is improved, and the problem of inefficiency in the existing technology is solved. An efficient animal model was used to study large fragment deletion diseases of genomes.
Patent Information
- Application Number
- CN202210758278.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-06-30
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2042-06-30
AI Technical Summary
In the prior art, the deletion of large genomic fragments is low, and it is difficult to effectively construct an animal model for studying disease caused by the deletion of large genomic fragments.
By using the CRISPR system in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters, no less than three specific CRISPR gRNA target sequences are designed, combined with Cas9 protein microinjection, optimize gRNA combination and injection parameters, and improve the genome The efficiency of large fragment deletion.
The efficiency of deletion of large genomic fragments was significantly improved, with an average efficiency of 64.5% and a maximum efficiency of 100%. The 340kb ttn1-ttn2 ultra-long fragment was successfully deleted, providing an efficient animal model for studying large genomic fragment deletion diseases.
Smart Images

Figure CN115074390B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of molecular biology, and specifically relates to a method and application for efficiently constructing a large genome deletion mutant, in particular, utilizing a CRISPR system to delete large genome fragments in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters, and efficiently constructing an animal model for studying diseases caused by large genome deletions. Background Art
[0002] The CRISPR / Cas system is an RNA-mediated adaptive defense system evolved from bacteria and archaea. Its main function is to protect organisms from invading viruses and plasmids, and to cut foreign genes using guide RNA nucleases. Compared with zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), the CRISPR system destroys target genes by causing small insertions and deletions (indels) through non-homologous end joining that leads to repair errors. It has been widely used to perform mutations in various organisms. The CRISPR / Cas9 system has the advantages of simple operation, easy synthesis, high targeting efficiency, precise targeting, and low cytotoxicity. In addition, while ensuring that genes are mutated in somatic cells, it can also cause mutations in germ cells, thereby passing on mutated genes to the next generation.
[0003] However, insertion / deletion marker (indel) mutagenesis is not suitable for all targets: multiple transcript variants or alternative start codons (whether annotated or not) may exist in the same gene, making it difficult to determine whether a functional protein product is destroyed by limited local mutations; for non-coding RNA (ncRNA) genes, untranslated regions or regulatory regions, local mutations are unable to destroy the function of these genes or cis-elements, and it is also difficult to simultaneously remove multiple genes or a group of adjacent genes on a chromosome by targeting only a single locus. Combinatorial deletion of long genomic fragments through CRISPR provides an effective tool for realizing the function of coding genes and non-coding genes.
[0004] Currently, large fragment deletion technology has been applied to mammals, fish, plants, bacteria, fungi and other organisms ( Fig.12). In CRISPR / Cas9-mediated fragment deletion, the common method is to set a target site at each end of the pre-deleted fragment. A few adopt the method of setting two pairs at each end. David et al. designed a 1.2kbp deletion for the upstream key regulatory sequence of the TYR pigment gene in mammalian mice. By microinjecting a pair of gRNA and Cas9 at different concentrations into mouse fertilized eggs, they successfully constructed mice with reduced pigmentation and verified the function of the regulatory sequence. At the same time, it was found that the efficiency of fragment deletion increased from 23% to 36% when the concentrations of Cas9 mRNA and gRNA were increased. Xiao et al. targeted the zebrafish genome and injected a pair of CRISPR or two pairs of TALENs into zebrafish embryos to obtain mutants and their offspring, but many did not detect the deletion efficiency. In addition, the 105kbp TYR gene was deleted in rabbits by mixing Cas9 mRNA with two pairs of gRNA targets, with the highest efficiency reaching 25%. In rice, a plasmid containing Cas9 protein and a pair of gRNA was transferred, in which a 245kbp fragment was deleted with an efficiency of 16.7%. Since bacteria have poor repair ability for double-strand breaks, Standage-Beier et al. used Cas9 Nickase, which cuts single strands, to delete E. coli genes. This nuclease is expensive, and two complementary gRNAs are required to target one site. By mixing two pairs of gRNA and Cas9 Nickase targeting two sites, 36 and 97 kb fragments were deleted in E. coli, with deletion success rates of 20% and 1%, respectively. In addition, there are also reports of large fragment deletion in soybeans. In summary, the deletion of large genomic fragments in various species, the fragment deletion distance ranges from a few hundred base pairs to nearly one megabase, and the efficiency of fragment deletion is between 1% and 36%. The average efficiency of fragment deletion in model organisms such as mice, rabbits, zebrafish, E. coli, soybeans, and rice is below 25%, and the efficiency is generally low. In addition, the above work uses injection of Cas9 and less than 2 pairs of gRNA for large fragment deletion, lacking the operational steps to evaluate and optimize the gRNA combination.
[0005] The number of diseases with genomic fragment deletion accounts for about 17.7% of the total number of diseases. Fragment deletion can be used to study the functions of gene families, regulatory elements, etc., thereby revealing the mechanism of the disease. Using model organisms to construct mutants can not only meet the needs of basic research, but also be used for drug screening to help find possible drugs. Mutations in the ttn1 and ttn2 genes encoding titin are associated with human skeletal and cardiac myopathy. The hox gene cluster encodes a transcriptional regulatory family that shapes the head-tail axis of animals during development. Hox gene mutations or deletions can lead to a series of developmental disorders. Single-site knockout using CRISPR can introduce local gene mutations, resulting in abnormal gene expression and inability to synthesize normal proteins. However, there are a large number of genes or regulatory elements in the DNA of organisms that do not directly express proteins, but affect protein synthesis indirectly. Single-site knockout sometimes does not have the effect of knocking out these regulatory elements. If you want to edit these regulatory elements or gene clusters, you need to use fragment deletion. In plants and animals, fragment deletion can be used to study crop trait genes, delete reverse regulatory elements, and achieve precise molecular breeding. In the field of microbial industry, antibiotics, pesticides, etc. can be made from the secondary metabolites of bacteria and fungi themselves. Deleting certain genes by fragment can make them more resistant to storage or increase yield. In medicine, fragment deletion can be used to study the functions of long fragments or clustered gene families. Therefore, whether in the fields of medicine, agriculture or industrial production, improving the efficiency of gene editing is of great significance. At present, the efficiency of fragment deletion is generally low, and it is necessary to further develop efficient means of genome fragment deletion. Summary of the invention
[0006] In order to solve the problem of low efficiency of large genome fragment deletion in the prior art, the main purpose of the present invention is to provide a method for efficiently constructing large genome fragment deletion mutants, especially to delete large genome fragments in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters through the CRISPR system, thereby greatly improving the efficiency of large genome fragment deletion.
[0007] Another object of the present invention is to provide an application of the above-mentioned method for efficiently constructing a large genomic fragment deletion mutant in efficiently constructing an animal model for studying diseases caused by large genomic fragment deletion.
[0008] The objective of the present invention is achieved through the following technical solutions:
[0009] The method for efficiently constructing a large genome fragment deletion mutant provided by the present invention comprises the following steps:
[0010] S1. Determine the target sequence for gene deletion in the gene cluster of the treatment object, and design no less than three specific CRISPR gRNA target sequences at both ends of the gene fragment to be deleted under the condition of conforming to the CRISPR PAM region;
[0011] S2. Design amplification primers according to the specific CRISPR gRNA target sequences designed in step S1;
[0012] S3, using the gRNA backbone plasmid as a template, using primer T7-gRNA target as a forward primer and gRNA reverse primer to perform PCR amplification to obtain a PCR product;
[0013] S4. Purify the PCR product obtained in step S3, transcribe in vitro, and obtain several gRNAs;
[0014] S5, in step S4, the gRNA and Cas9 protein are respectively microinjected into the one-cell stage fertilized egg of the treatment object;
[0015] S6, selecting the embryonic stage eggs of the treatment object described in step S5 to extract the genome, and performing PCR amplification with knockout target detection primers to obtain PCR products;
[0016] S7, the PCR product obtained in step S6 is subjected to enzyme digestion and agarose gel electrophoresis in sequence, and the grayscale value of the bands is detected by the quantitative tool of Image Lab software to obtain the brightness volume of each band a, b and c, and the knockout efficiency is calculated according to the formula indel% = (a+b) / (a+b+c)×100%;
[0017] S8. Form several groups of optimal target combinations from the specific CRISPR target sites at both ends of the gene fragment to be deleted;
[0018] S9, selecting at least three groups of optimal target combinations in step S8 and respectively microinjecting them into the one-cell stage fertilized eggs of the treatment object;
[0019] S10, selecting the embryonic stage eggs of the treatment object described in step S9 to extract the genome, performing double outer primer PCR amplification and agarose gel electrophoresis, and performing stable culture to obtain a large genome deletion mutant.
[0020] Preferably, in step S8, specific CRISPR targets with high and similar T7E1 cleavage activity are selected from the specific CRISPR targets at both ends of the gene fragment to be deleted as the optimal target combination.
[0021] Preferably, the method for efficiently constructing a large genome deletion mutant satisfies the following requirements:
[0022] (1) The large genomic fragment deletion efficiency of the treated object is positively correlated with the mutagenesis efficiency of its single specific CRISPR target, and negatively correlated with the difference in gRNA efficiency at both ends of the gene fragment to be deleted;
[0023] (2) The gene length between any two specific CRISPR target sites has no significant effect on the efficiency of large fragment deletion;
[0024] (3) Compared with the simultaneous microinjection of no less than two specific CRISPR targets, the microinjection of the optimal target combination with high mutagenesis efficiency in step S9 has a high efficiency in deleting large genomic fragments.
[0025] Preferably, in step S6, the knockout target detection primer is a specific primer that can amplify the target.
[0026] Preferably, in step S5, the final concentration of gRNA is 100-200 ng / μL, the final concentration of Cas9 protein is 800 ng / μL, the final concentration of Cas9 mRNA is 400 ng / μL, and the injection volume is 1 nL.
[0027] Preferably, the method for efficiently constructing large genome deletion mutants is used to delete large genome fragments in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters, comprising the following steps:
[0028] (1) Determine the target sequence for gene knockout in the zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters, and design no less than three specific CRISPR gRNA target sequences at both ends of the gene fragment to be deleted under the condition that the CRISPR PAM region is met;
[0029] (2) designing amplification primers according to the specific CRISPR gRNA target sequence designed in step (1);
[0030] (3) Using the gRNA backbone plasmid as a template, using primer T7-gRNA target as a forward primer and gRNA reverse primer to perform PCR amplification to obtain a PCR product;
[0031] (4) Purifying the PCR product obtained in step (3), and in vitro transcribing to obtain gRNA;
[0032] (5) microinjecting the gRNA and Cas9 protein obtained in step (4) into one-cell stage fertilized eggs of zebrafish;
[0033] (6) extracting genomes from eggs of zebrafish at 48 h embryonic stage in step (5), and performing PCR amplification using knockout target detection primers to obtain PCR products;
[0034] (7) The PCR product obtained in step (6) was subjected to T7E1 restriction enzyme detection and agarose gel electrophoresis in turn, and the grayscale value of the bands in the obtained gel image was detected using the quantitative tool of Image Lab software to obtain the brightness volume of each band a, b and c, and the knockout efficiency was calculated according to the formula indel% = (a+b) / (a+b+c)×100%;
[0035] (8) selecting no less than three groups of specific CRISPR targets from the specific CRISPR targets at both ends of the gene fragment to be deleted to form the optimal target combination;
[0036] (9) microinjecting the optimal target combination obtained in step (8) into one-cell stage fertilized eggs of zebrafish;
[0037] (10) The zebrafish eggs at the 48h embryonic stage in step (9) were selected to extract the genome, and double outer primer PCR amplification and agarose gel electrophoresis were performed in sequence, and the zebrafish genome large fragment deletion mutant was obtained by stable culture.
[0038] Preferably, in step (1), the target sequence is as shown in the following table:
[0039]
[0040]
[0041] Preferably, in step (2), the sequences of the amplification primers are as shown in the following table:
[0042]
[0043]
[0044]
[0045] The present invention also provides application of the method for efficiently constructing a large-fragment deletion mutant of a genome in deleting a large gene fragment in the genome of a vertebrate.
[0046] The present invention also provides application of the method for efficiently constructing a large genome fragment deletion mutant in constructing an animal model for disease treatment and drug screening caused by large genome fragment deletion.
[0047] Compared with the prior art, the present invention has the following beneficial effects:
[0048] First, the present invention first screens out gRNAs with high mutation efficiency, and then selects gRNAs with smaller efficiency differences for combined microinjection into one-cell stage zebrafish fertilized eggs. For the first time, CRISPR single-site efficiency evaluation is used to screen out CRISPR combinations that produce efficient large genome deletions, while satisfying the following requirements: 1) The large genome deletion efficiency is positively correlated with the mutagenesis efficiency of a single specific CRISPR target, and negatively correlated with the difference in gRNA efficiency at both ends of the gene fragment to be deleted; 2) The gene length between any two specific CRISPR targets has no significant effect on the large fragment deletion efficiency; 3) Microinjection of the optimal target combination with high mutagenesis efficiency has a higher large genome deletion efficiency than simultaneous microinjection of no less than two specific CRISPR targets.
[0049] Second, the present invention designs gRNAs for different genomic sites of zebrafish, co-injects a pair of gRNAs and Cas9 proteins for specific gene clusters into one-cell embryos, and uses the CRISPR / Cas system to delete large genomic fragments in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters. The length of the deleted genomic fragments ranges from 5 to 340 kb, with an average efficiency of 64.5% and a maximum efficiency of 100% (20 / 20). At the same time, the 340 kb ttn1-ttn2 cluster ultra-long fragment is successfully deleted with a high efficiency of 95%, greatly improving the efficiency of large genomic fragment deletion. The existing reported fragment deletion distance is from a few hundred base pairs to nearly one megabyte, and the efficiency of fragment deletion is between 1% and 36%. The average efficiency of fragment deletion in model organisms such as mice, rabbits, zebrafish, Escherichia coli, soybeans, and rice is below 25%, which is generally low in efficiency. In addition, large fragment deletion is performed by injecting Cas9 and less than 2 pairs of gRNAs, and there is a lack of operating steps for evaluating and optimizing gRNA combinations.
[0050] 3. The method of the present invention achieves efficient fragment deletion in the hoxab (33.3 kb), hoxca (138.1 kb), hoxcb (48.3 kb), hoxda (53.3 kb), and nppb-nppa gene clusters of zebrafish, and the obtained zebrafish genome large fragment deletion mutant can be used as an animal model for studying large genome fragment deletion diseases. In addition, the present invention obtains the hoxca gene cluster deletion mutant in zebrafish for the first time and produces the corresponding fish dorsal fin deletion phenotype, providing a model for the study of fish dorsal fin development. BRIEF DESCRIPTION OF THE DRAWINGS
[0051] Figure 1 It is a schematic diagram of the mode of large genomic fragment deletion in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters in the embodiment.
[0052] Figure 2 It is a schematic diagram of agarose gel electrophoresis and ImageLab gray value (brightness volume) quantification in the CRISPR-mediated zebrafish genome large fragment deletion method in the embodiment, and the unit site enzyme cutting efficiency calculation formula is indel%=(a+b) / (a+b+c)×100%.
[0053] Figure 3 This is a gel image showing the detection of T7E1 enzyme digestion efficiency of the ttn1, ttn2, hoxa13b, hoxa2b, hoxc1a, hoxc4a, hoxc6a, hoxc9a, hoxc11a, hoxc13a, hoxc6b, hoxc13b, nppb and nppa gene target sites in the embodiments.
[0054] Figure 4 The figure is a schematic diagram of hoxcb deletion and a statistical bar graph of the unit site efficiency and fragment deletion efficiency of the hoxcb cluster, unit site efficiency: T7E1 efficiency, fragment deletion efficiency: knockout efficiency; where: (A) schematic diagram of the hoxc6b-hoxc13b gene cluster and target site; (B) unit site efficiency, mean and fragment deletion efficiency of hoxc6b T1 and hoxc13b T2; (C) unit site efficiency, mean and fragment deletion efficiency of hoxc6b T1 and hoxc13b T1; (D) unit site efficiency, mean and fragment deletion efficiency of hoxc6b T2 and hoxc13b T2; (E) unit site efficiency, mean and fragment deletion efficiency of hoxc6b T2 and hoxc13b T1. From (B) to (E), the fragment deletion efficiency increases with the increase of the unit site efficiency mean, showing a positive correlation.
[0055] Figure 5 The deletion results of the tn1-ttn2 gene cluster in the embodiment; wherein: (a) a bar graph of the ttn1-ttn2 cluster fragment deletion efficiency (fra-del efficiency) and the difference in target efficiency (indel efficiency difference). In the two fragment deletions of the ttn1-ttn2 cluster, the difference in fragment deletion efficiency and target efficiency is negatively correlated; (b) a gel image of the detection of the tt1-ttn2 target knockout efficiency; (c) a gel image of the detection of the knockout efficiency of each fragment of the ttn1-ttn2 cluster.
[0056] Figure 6The figures are the results of the deletion of the Hoxab gene cluster in the embodiment; wherein: (a) a bar graph showing the difference between the Hoxab cluster fragment deletion efficiency and the target efficiency. In the two fragment deletions of the Hoxab cluster, the difference between the fragment deletion efficiency and the target efficiency is negatively correlated; (b) a gel image showing the detection of the Hoxab target knockout efficiency; and (c) a gel image showing the detection of the knockout efficiency of each fragment of the Hoxab cluster.
[0057] Figure 7 The results of Hoxca deletions of different fragment lengths: (A) Schematic diagram of the Hoxca gene cluster and the targets of four deletion methods: 55.7Kb, 71.4Kb, 91.6Kb, and 133.9Kb; (B) Gel image of the fragment deletion results generated by the combination of the four Hoxca targets. (C) Statistical bar graph of the single-site deletion efficiency of the five Hoxca targets; (D) Statistical graph of the four fragment deletion efficiencies of the Hoxca cluster; (E) Line graph of the Hoxca cluster fragment deletion efficiency and deletion length, fragment deletion efficiency is not related to fragment deletion length.
[0058] Figure 8 : is a comparison diagram of the fragment deletion efficiency of multiple targets and a pair of target points in the embodiment; wherein: (A) fragment deletion pattern diagram of different target combinations, first row: target A1 is located at the 5' end of gene1, and target A2 is located at the 3' end of gene n; second row: target A1 is located at the 5' end of gene1, and targets A3 and A2 are located at the 3' end of gene n; third row: targets A1 and A4 are located at the 5' end of gene1, and target A2 is located at the 3' end of gene n; fourth row: targets A1 and A4 are located at the 5' end of gene1, and targets A3 and A2 are located at the 3' end of gene n; (B) fragment deletion efficiency bar graph of four target combinations of hoxca cluster, the four combinations from top to bottom correspond to the first to fourth rows in the pattern diagram of (A) respectively; (C) fragment deletion efficiency bar graph of four target combinations of ttn cluster, the four combinations from top to bottom correspond to the first to fourth rows in the pattern diagram of (A) respectively.
[0059] Fig. 9 The following are pictures of the F1 generation mutant zebrafish with hoxca cluster deletion in the embodiment, which produce a dorsal fin-free phenotype; wherein: (A) hoxca cluster deletion pattern diagram, the front target is located on the first exon CDS of hoxc13a, and the rear target is located on the second exon CDS of hoxc1a; (B) overall photo of the offspring produced by the cross between the hoxca fragment deletion mutant and the wild type, three months old, all shown are male fish, with a dorsal fin (left), and the genotype was subsequently identified as WT sibling; no dorsal fin phenotype, the genotype was subsequently identified as hoxca + / -; (C) Electrophoresis of PCR amplification using double outer primers of the hoxca cluster after tail clipping of fish with no dorsal fin phenotype. Fish 1-5 without dorsal fin: one band (marked with a star), siblings C1, C2, and C3 with dorsal fin have no band; (D) Sequencing results, Ref is the NCBI reference wild-type sequence, and #3 is the sequencing result of fish No. 3 in (C).
[0060] Fig.10 The hoxcb cluster fragment deletion results in the embodiment; wherein: (A) electrophoresis diagram of hoxc13b T1 and hoxc6b T1 fragment deletion, efficiency is 14 / 20; (B) sequencing results of randomly selected amplified products in (A); (C) electrophoresis diagram of hoxc13b T2 and hoxc6b T2 fragment deletion, efficiency is 13 / 20; (D) electrophoresis diagram of hoxc13b T2 and hoxc6b T1 fragment deletion, efficiency is 13 / 20; below is the result of sequencing of randomly selected amplified products in (D).
[0061] Fig.11 The results of highly efficient deletion of the 340kb ttn1-ttn2 super-long fragment in the example; (A) agarose gel electrophoresis of T7E1 digestion detection of knockout efficiency of ttn1 T5 and ttn2 T3; (B) gel image of efficiency detection of fragment deletion results produced by co-injection of ttn1 T5 and ttn2 T3 targets; (C) statistical results of long fragment deletion efficiency of various species.
[0062] Fig.12 It is a statistical diagram of the fragment deletion efficiency of each species, wherein * is the fragment deletion efficiency of zebrafish by the method of the present invention, and the others are the statistical fragment deletion efficiencies in Bacillus thuringiensis, Escherichia coli, Saccharomyces cerevisiae, rice, soybean, mouse, and rabbit. DETAILED DESCRIPTION
[0063] In order to make the purpose, technical solution and advantages of the embodiment of the present invention clearer, the technical solution of the embodiment of the present invention will be clearly and completely described in conjunction with the drawings of the embodiment of the present invention. Obviously, the described embodiment is a part of the embodiment of the present invention, not all of the embodiments. Based on the described embodiment of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.
[0064] In the following embodiments, Figure 1 As shown, the method for efficiently constructing large genome deletion mutants in the present invention is used to delete large genome fragments in zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters, and the ttn gene cluster is used as an example for reverse fragment knockout. The scissors indicate the position of Cas9 cutting, and the length of the gene cluster and the distance between the two genes are marked on the figure ( Figure 1 , A); Taking the Hox gene cluster as an example, its knockout pattern completely marks the length of each Hox gene cluster and the distance between the genes at both ends of each gene cluster ( Figure 1 , B); Taking nppa-nppb as an example, its knockout pattern fully marks the length and the distance between the genes at both ends of the gene cluster ( Figure 1 , C)
[0065] Example 1
[0066] This embodiment follows Figure 1 The method described above is to construct a zebrafish genome large fragment deletion mutant, specifically as follows:
[0067] (I) Experimental subjects. The wild-type zebrafish used were AB type, and all mutant fish lines were constructed by the inventors in accordance with the relevant animal ethics regulations of Shanghai Ocean University (IACUC SHOU-DW-2021-042). Experimental conditions: With complete zebrafish breeding equipment, the living environment of zebrafish is a circulating water system that has been treated with UV and aeration, the water temperature is 28.5℃, the pH value and conductivity are within normal indicators, and the light is strictly in accordance with the requirements of 10h of darkness + 14h of light per day. Zebrafish mate and lay eggs in a special spawning tank, and the collected zebrafish eggs are placed in a constant temperature incubator at 28.5℃ for culture. Generally, the membrane begins to break at about 48h. Before the membrane breaks, the water is changed once in the morning and evening and the dead eggs are sucked out. After the membrane breaks, the water is changed once a day. After 5 days, paramecium is fed, and after 20 days, Artemia is fed. It is fed in the circulation system for about a month, and it is raised in separate tanks for one and a half months, paying attention to gender differentiation.
[0068] (ii) Plasmid. The gRNA backbone plasmid used was from the literature: Chang N, Sun C, Gao L, Zhu D, Xu X, Zhu X, Xiong JW, Xi JJ. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos, Cell Res, 2013, 23(4): 465-472.
[0069] (III) Main reagents. The experimental reagents are shown in Table 1:
[0070] Table 1
[0071] Reagents Source and item number Taq enzyme Vazyme, P213-03 Endonuclease XbaⅠ NEB, R0145S T7E1 endonuclease Vazyme, EN303-01 MAXIscript T7 Invitrogen, 00688273 mMESSAGEmMACHINE T7 ULTRA kit Invitrogen, AM1345 GenCrispr NLS-Cas9-NLS Nuclease GenScript, Z03389-100
[0072] (IV) Main instruments: UV spectrophotometer (Thermo Scientific company—Nanodrop2000C), water purifier (Merck Millipore company—Milli-Q Direct 8), -40℃ low temperature refrigerator (Haier—DW-40L508), large centrifuge (Eppendorf company—Centrifuge 5810R), constant temperature incubator (SANYO company—MIR-262), high pressure steam sterilizer (SANYO company—MLS-3780), electrophoresis instrument (BIO-RAD—PowerPac Basic), 4℃ refrigerator (Haier—HYC-610), gel imager (BIO-RAD company—Gel Doc EZImager), oscillating mixer (VORTEX-GENIE company—G560E), PCR amplification instrument (BIO-RAD company—C1000 Touch), -80℃ ultra-low temperature refrigerator (Panasonic company—MDF-U53V), constant temperature water bath (brand: Jinghong, model: H1401438, DK-8D), glass capillary (brand: WPI, model: TW100F-4), vertical needle puller (brand: NARISHIGE, model: PC-10).
[0073] (V) Construction of zebrafish genome large fragment deletion mutants
[0074] 1. gRNA synthesis
[0075] (1) Target design
[0076] Search the sequence of zebrafish genes on the Ensembl website, and find suitable gRNA on the ZIFIT website. After the gRNA design is completed, first perform BLAST on the NCBI website to test the specificity. When sending the company to synthesize the target primer, confirm whether the target is the positive chain or the antisense chain to avoid design errors. The target sequence information is shown in Table 2. The T7 promoter sequence TAATACGACTCACTATA is added to the 5' end, and the gRNA backbone reverse primer sequence GTTTTAGAGCTAGAAAT is added to the 3' end, and sent to the company to synthesize the primer.
[0077] Table 2
[0078]
[0079]
[0080] (2) Design of detection primers
[0081] The detection primers contain target sites at both ends. The upstream detection primer is located 200 bp outside the front end of the upstream target, and the downstream detection primer is located 200 bp outside the back end of the downstream target, ensuring that the PCR amplification product has a length greater than 400 bp to clearly distinguish different bands. When detecting the efficiency of large fragments, double outer primers are selected, for example, F of the upstream target and R of the downstream target form a pair of primers. The primers were synthesized by Shanghai Sangon Biotechnology Co., Ltd., and the primer information is shown in Table 3.
[0082] Table 3
[0083]
[0084]
[0085] (3) Synthesize gRNA in vitro transcription template
[0086] a. Using the gRNA backbone plasmid as a template, perform PCR reaction with the forward primer corresponding to the target in Table 2 and the gRNA reverse primer.
[0087] b. PCR reaction conditions are as follows: pre-denaturation at 94°C for 3 min; denaturation at 94°C for 30 s; annealing at 65°C for 30 s; extension at 72°C for 30 s; 35 cycles; 72°C for 10 min; and finally keeping in a refrigerator at 4°C.
[0088] c. Detect the PCR product by 2% agarose gel electrophoresis (Gel EP) at 120V for 20min. The band is slightly longer than the marker band of 100bp in length.
[0089] d. First purify with a DNA purification kit, and then dissolve and elute with RNase-Free water.
[0090] e. Take 0.5-1uL of solution and measure the concentration using Nanodrop spectrophotometer.
[0091] (4) In vitro transcription
[0092] Under RNase-Free conditions, the above PCR purified products were subjected to in vitro transcription to obtain gRNA. The transcription system was referred to the instructions of the in vitro transcription kit, as shown in Table 4, where T7 enzyme mix was added last; the reaction conditions were: 37°C water bath, 90 min; then 1 μL of TURBO DNase was added, 37°C water bath, 15 min.
[0093] Table 4
[0094] RNase free water to 20μL gRNA plasmid Template 1 μg 10×Transcription Buffer 2μL 10mM ATP 1μL 10mM CTP 1μL 10mM GTP 1μL 10mM UTP 1μL T7 Enzyme Mix 2μL
[0095] After mixing and briefly centrifuging, incubate at 37°C for 80 min. Then, add 1 μL of TURBO DNase to the system and mix, briefly centrifuge and incubate at 37°C for 15 min.
[0096] (5) Precipitation and purification of gRNA
[0097] After in vitro transcription, gRNA was purified by LiCl precipitation as follows:
[0098] a. Add 2 μL of 4M LiCl to the above reaction product, and then add 200 μL of 100% ethanol; store in a -80°C refrigerator for 2-12 hours (can be processed overnight).
[0099] b. Centrifuge at 4°C and 12,000 rpm for 30 min, and remove the supernatant by decantation or using a pipette.
[0100] c. Use a pipette to absorb pre-cooled 70% ethanol to wash the precipitate, and gently blow the precipitate to suspend it. Then centrifuge at 4°C, 12,000 rpm for 10 minutes, remove the supernatant, repeat this step once to remove impurities, and air dry in a clean bench at room temperature for 5 minutes.
[0101] d. Add 10 μL RNase-free water to dissolve.
[0102] e. Nanodrop detection of concentration; 150V, 15min, 1% agarose gel electrophoresis to detect synthesis quality.
[0103] 2. Microinjection
[0104] Cas9 protein or Cas9 mRNA and gRNA are pre-prepared into a mixed solution in a certain proportion. The final concentration is: gRNA 100-200ng / μL, Cas9 protein 800ng / μL, Cas9 mRNA 400ng / μL. Inject it into the animal pole of the zebrafish embryo at the 1-cell stage. Inject 1nL and detect it after 24 hours. During the injection, a part of the uninjected fish eggs needs to be retained as a control.
[0105] 3. T7E1 enzyme digestion to detect knockout efficiency
[0106] a. After 24 hours, three groups of 5 embryos were selected and placed in PCR tubes for genome extraction using alkaline lysis method: 50uL 50mM NaOH solution was added to each tube, incubated at 95℃ for 10min, then taken out and fully shattered the tissue on a shaker; continued at 95℃ for 10min; added 5uL 1M Tris-HCl (pH=8), shaken to mix, and centrifuged at 10000rpm for 5min.
[0107] b. PCR amplification of the DNA fragment containing the target site
[0108] The target fragment was amplified using the double outer primers corresponding to the injection group in Table 3. The PCR reaction system is shown in Table 5 below:
[0109] Table 5
[0110] <![CDATA[ddH2O]]> 9.5μL PCR mix 2× 12.5μL F 1μL R 1μL Template 1μL
[0111] PCR reaction conditions: 95°C pre-denaturation for 3 min; 95°C denaturation for 30 sec, 60°C annealing for 30 sec, 72°C extension for 40 sec, 35 cycles in total; 72°C extension for 10 min; 12°C storage. 2% agarose gel electrophoresis at 120 V for 25 min.
[0112] c. T7E1 enzyme for knockout efficiency detection
[0113] The T7E1 enzyme digestion detection reaction system is shown in Table 6:
[0114] Table 6
[0115] PCR products 5μL Reaction Buffer 1.1μL <![CDATA[ddH2O]]> up to 10μL
[0116] The reaction conditions were: 95°C, 30s; 85°C, 5min; 4°C, 5min; after the reaction, 0.25μL T7E1 enzyme was added and incubated at 37°C, 45min. 120V, 25min, and detected by 2% agarose gel electrophoresis.
[0117] d. Agarose gel electrophoresis
[0118] The electrophoresis results were imaged using a Bio-Rad gel imager to observe the number of bands. The WT should have one band, and the experimental group (enzyme digestion group) should have 2 to 3 bands. The gray value of the electrophoresis image was analyzed using ImageLab software to calculate the knockout efficiency ( Figure 2 ).
[0119] 4. Experimental results
[0120] (1) Ttn1, ttn2, hoxa13b, hoxa2b, hoxc1a, hoxc4a, hoxc6a, hoxc9a, hoxc11a, hoxc13a, hoxc6b, hoxc13b, nppb, nppa gene target efficiency T7E1 digestion Figure 3As shown, from top to bottom are the target efficiency enzyme cleavage diagrams of TTN1 (T2, T3, T4, T5), TTN2 (T1, T2, T3, T4), Hoxa13b (T1, T2), Hoxa2b (T1, T2), Hoxc1a (T1), Hoxc4a (T2), Hoxc6a (T2), Hoxc9a (T2), Hoxc11a (T1), Hoxc13a (T1, T2), Hoxc6b (T1, T2), Hoxc13b (T1, T2), NPPb (T1, T2), and NPPa (T1, T2).
[0121] (2) Statistical results of Hoxc6b-Hoxc13b fragment deletion efficiency and single-site efficiency
[0122] Two targets, T1 and T2, are set on hoxc6b, and two targets, T1 and T2, are set on hoxc13b ( Figure 4 , A). The four combinations of these four targets were subjected to fragment deletion to obtain deletion efficiency. The average single-site efficiency of the hoxc6b T1, hoxc13b T2 combination was 41%, and the fragment deletion efficiency was 55% ( Figure 4 , B), the average single-site efficiency of the combination of hoxc6b T1 and hoxc13b T1 is 47%, and the fragment deletion efficiency is 60% ( Figure 4 , C), the average single-site efficiency of the combination of hoxc6b T2 and hoxc13b T2 was 57.5%, and the fragment deletion efficiency was 65% ( Figure 4 , D), the average single-site efficiency of the combination of hoxc6b T2 and hoxc13b T1 was 63.5%, and the fragment deletion efficiency was 70% ( Figure 4 , E). The statistical results show that the efficiency of fragment deletion is positively correlated with the mean of single-site efficiency.
[0123] (3) Ttn1-ttn2 fragment deletion results
[0124] First, we randomly selected 6 of the ttn cluster targets we designed to verify the knockout efficiency of the single site. The selected targets were ttn1 T1, ttn1 T2, ttn1 T3, ttn2 T1, ttn2 T2, and ttn2 T5. Among them, ttn1 T1 and ttn2 T5 were inefficient targets; the ttn1 T3 control group had mixed bands. Therefore, ttn1 T2, ttn2 T1, and ttn2 T2 were selected for fragment knockout. The difference between the ttn1-ttn2 cluster fragment deletion efficiency and the target efficiency is shown in the column comparison. Figure 5 As shown in a, the enzyme digestion efficiencies of ttn1 T2, ttn2 T1, and ttn2T2 were 46.2%, 33.3%, and 44.2%, respectively. Figure 5, b). The knockout efficiency of each fragment of the ttn1-ttn2 cluster was statistically analyzed, and it was found that the knockout efficiency of the ttn1 T2-ttn2 T1 fragment was 11 / 22 (50%), and that of the ttn1 T2-ttn2 T2 was 14 / 22 (63.6%) ( Figure 5 , c).
[0125] (4) Results of Hoxa13b-Hoxa2b fragment deletion
[0126] Since the first and last exons of the Hoxab gene cluster are short, it is impossible to find more targets to accurately delete the entire gene cluster. Therefore, two targets are set at each end for screening. The targets are Hoxa2b T1, Hoxa2b T2, Hoxa13b T1, and Hoxa13b T2. The difference between the deletion efficiency of the Hoxa13b-Hoxa2b cluster fragment and the target efficiency is shown in the following figure. Figure 6 As shown in a, the enzyme digestion efficiencies of hoxa2b T1, hoxa2b T2, hoxa13b T1, and hoxa13b T2 were 84.8%, 54.5%, 59.5%, and 65.8%, respectively. Figure 6 , b), the knockout efficiency of each fragment of the Hoxa13b-Hoxa2b cluster was statistically analyzed, and it was found that the knockout efficiency of the Hoxa13b T1, Hoxa2b T1 fragment was 9 / 20 (45%), the Hoxa13b T2, Hoxa2b T1 was 15 / 20 (75%), the Hoxa13b T2, Hoxa2b T2 was 17 / 20 (85%), and the Hoxa13b T1, Hoxa2b T2 was 20 / 20 (100%) ( Figure 6 , c).
[0127] (5) Statistical results of deletion efficiency of fragments of different lengths in the hoxca gene cluster
[0128] Four deletion modes of 55.7Kb, 71.4Kb, 91.6Kb and 133.9Kb were set for the hoxca gene cluster ( Figure 7 , A), the fragment deletion efficiency was detected after double outer primer PCR ( Figure 7 , B), the fragment deletion efficiency is hoxc1a-hoxc4a: 65%, hoxc1a-hoxc6a: 70%, hoxc1a-hoxc9a: 35%, hoxc1a-hoxc13a: 60%. At the same time, the single-site efficiency of the five target sites used on the hoxc1a, hoxc4a, hoxc6a, hoxc9a, and hoxc13a genes was calculated ( Figure 7, C), hoxc1a: 57%, hoxc4a: 88%, hoxc6a: 56%, hoxc9a: 69%, hoxc13a: 72%. The bar graphs of different fragment deletions were statistically analyzed ( Figure 7 , D). Through line graph statistics, it is found that the fragment deletion length does not affect the fragment deletion efficiency, that is, the fragment deletion efficiency is not related to the fragment deletion length ( Figure 7 , E).
[0129] (6) Comparison of fragment deletion efficiency between multiple targets and a pair of targets. Different target combinations for fragment deletion mode ( Figure 8 , A), first row: target A1 is located at the 5' end of gene1, and target A2 is located at the 3' end of gene n; second row: target A1 is located at the 5' end of gene1, and targets A3 and A2 are located at the 3' end of gene n; third row: targets A1 and A4 are located at the 5' end of gene1, and target A2 is located at the 3' end of gene n; fourth row: targets A1 and A4 are located at the 5' end of gene1, and targets A3 and A2 are located at the 3' end of gene n.
[0130] The deletion efficiency of four target combinations of the Hoxca cluster Figure 8 , B), the four combinations from top to bottom correspond to the first to fourth rows in the pattern diagram (A). The fragment deletion efficiency bar graph of the four target combinations of the ttn cluster ( Figure 8 , C). The four combinations from top to bottom correspond to the first to fourth rows in the pattern diagram (A).
[0131] (7) Hoxca cluster deletion mutant zebrafish produce a dorsal fin-less phenotype
[0132] The Hoxca cluster deletion model has an anterior target site located on the first exon CDS of Hoxc13a and a posterior target site located on the second exon CDS of Hoxc1a ( Fig. 9 , A).
[0133] Overall photo of the offspring produced by the cross between the hoxca fragment deletion mutant and the wild type, three months old, all the pictures are male ( Fig. 9 , B), with dorsal fin (left), the genotype was later identified as WT sibling; without dorsal fin phenotype, the genotype was later identified as hoxca + / -.
[0134] Electrophoresis of the fish without dorsal fin phenotype after tail clipping using the Hoxca cluster double outer primers PCR amplification ( Fig. 9 , C). Fish without dorsal fin 1-5: present as a single stripe (star), siblings C1, C2, and C3 with dorsal fin have no stripe.
[0135] Ref is the NCBI reference wild-type sequence ( Fig. 9, D), #3 is the sequencing result of fish No. 3 in (C) ( Fig. 9 ).
[0136] (8) Hoxcb cluster fragment deletion results
[0137] The efficiency of deletion of Hoxc13b T1 and Hoxc6b T1 fragments by electrophoresis was 14 / 20 ( Fig.10 , A), randomly selected amplified products for sequencing results ( Fig.10 , B); the efficiency of deletion of hoxc13b T2 and hoxc6b T2 fragments by electrophoresis was 13 / 20 ( Fig.10 , C); the efficiency of deletion of hoxc13b T2 and hoxc6b T1 fragments by electrophoresis was 13 / 20 ( Fig.10 , D), the bottom of Figure D shows the sequencing results of randomly selected amplification products.
[0138] (9) Results of efficient fragment deletion of 340 kb ttn1-ttn2 cluster
[0139] The enzyme digestion efficiency of ttn1 T5 was 89.2%, and that of ttn2 T3 was 75.1% ( Fig.11 , A). After ttn1 T5 and ttn2 T3 were co-injected with Cas9 protein, embryos aged 48 hours were randomly selected for double outer primer PCR amplification, and the knockout efficiency was 95% (20 / 20) ( Fig.11 , B). This fragment deletion is the longest fragment deletion in the present invention, and the length of the fragment deletion (i.e., the distance between the two target sites) reaches 340kb ( Fig.11 , C, columns marked with *), which are longer than those performed in other species, and their efficiency of fragment deletion is higher than theirs ( Fig.11 , C).
[0140] (10) Statistical results of fragment deletion efficiency
[0141] The longest segment ttn1-ttn2 in the present invention is 340Kb long, and the deletion efficiency is 100% ( Fig.11 , C); the average efficiency of fragment deletion reached 64.5% ( Fig.12 , *), which is higher than the average efficiency of fragment deletion in other species.
[0142] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention. Sequence Listing <110> Shanghai Ocean University <120> Method and application for efficiently constructing large-fragment deletion mutants of genome <141> 2022-06-30 <160> 153 <170> SIPOSequenceListing 1.0 <210> 1 <211> 20 <212> DNA <213> Artificial Sequence <400> 1 ggaggccctg gcaacagaag 20 <210> 2 <211> 20 <212> DNA <213> Artificial Sequence <400> 2 ggaagcagca gctccggggg 20 <210> 3 <211> 20 <212> DNA <213> Artificial Sequence <400> 3 ggggaaggct ggatcgcata 20 <210> 4 <211> 20 <212> DNA <213> Artificial Sequence <400> 4 cattgatctc cattacaacc 20 <210> 5 <211> 20 <212> DNA <213> Artificial Sequence <400> 5 ggcggaaaga gaagtaaagg 20 <210> 6 <211> 20 <212> DNA <213> Artificial Sequence <400> 6 ggggtgtttc gggagcaaac 20 <210> 7 <211> 20 <212> DNA <213> Artificial Sequence <400> 7 ggaagacagt aaaaaaaggg 20 <210> 8 <211> 20 <212> DNA <213> Artificial Sequence <400> 8 gggtagtgct gcaacgttcg 20 <210> 9 <211> 20 <212> DNA <213> Artificial Sequence <400> 9 ccaatggtgc tggacaagcc 20 <210> 10 <211> 20 <212> DNA <213> Artificial Sequence <400> 10 ggatggtgat ttggctcata 20 <210> 11 <211> 20 <212> DNA <213> Artificial Sequence <400> 11 atcagaccag tgaagtctcc 20 <210> 12 <211> 20 <212> DNA <213> Artificial Sequence <400> 12 gggcccaacc gttctcacct 20 <210> 13 <211> 20 <212> DNA <213> Artificial Sequence <400> 13 gggccatgat gtctttttaa 20 <210> 14 <211> 20 <212> DNA <213> Artificial Sequence <400> 14 ggatagatta aacctgaggt 20 <210> 15 <211> 20 <212> DNA <213> Artificial Sequence <400> 15 caacaggtag agaggctccc 20 <210> 16 <211> 20 <212> DNA <213> Artificial Sequence <400> 16 tattgagaca accgaggacc 20 <210> 17 <211> 20 <212> DNA <213> Artificial Sequence <400> 17 ggtgtgaaag agaccgatgc 20 <210> 18 <211> 20 <212> DNA <213> Artificial Sequence <400> 18 gagcgctgtt tgcatttacc 20 <210> 19 <211> 18 <212> DNA <213> Artificial Sequence <400> 19 aaattcctcc ataacacc 18 <210> 20 <211> 20 <212> DNA <213> Artificial Sequence <400> 20 ggttcattgt atacagtgcg 20 <210> 21 <211> 20 <212> DNA <213> Artificial Sequence <400> 21 ggtgtttcct agcgtggtgc 20 <210> 22 <211> 20 <212> DNA <213> Artificial Sequence <400> 22 aacccgtcac ccactgttcc 20 <210> 23 <211> 20 <212> DNA <213> Artificial Sequence <400> 23 gcttacacct ctcagatgcc 20 <210> 24 <211> 20 <212> DNA <213> Artificial Sequence <400> 24 ggttctgctt gggccggctg 20 <210> 25 <211> 20 <212> DNA <213> Artificial Sequence <400> 25 ccattcccgc tggattgacc 20 <210> 26 <211> 20 <212> DNA <213> Artificial Sequence <400> 26 agacatgaat ctctactgcc 20 <210> 27 <211> 20 <212> DNA <213> Artificial Sequence <400> 27 acacgcacag catcagttcc 20 <210> 28 <211> 20 <212> DNA <213> Artificial Sequence <400> 28 ggcaagacac ttagaaaaat 20 <210> 29 <211> 20 <212> DNA <213> Artificial Sequence <400> 29 atgatttgac ccgccatccc 20 <210> 30 <211> 20 <212> DNA <213> Artificial Sequence <400> 30 ggcccacggc tctcaatatt 20 <210> 31 <211> 19 <212> DNA <213> Artificial Sequence <400> 31 ggctgttaga gctctttac 19 <210> 32 <211> 20 <212> DNA <213> Artificial Sequence <400> 32 ggaactcttc gttcaggtga 20 <210> 33 <211> 20 <212> DNA <213> Artificial Sequence <400> 33 ggggattttc ccgcctgacc 20 <210> 34 <211> 20 <212> DNA <213> Artificial Sequence <400> 34 tgcaagggac agtggctacc 20 <210> 35 <211> 20 <212> DNA <213> Artificial Sequence <400> 35 ccccttcggc tgcatcttcc 20 <210> 36 <211> 20 <212> DNA <213> Artificial Sequence <400> 36 acatgccact gaactcgacc 20 <210> 37 <211> 20 <212> DNA <213> Artificial Sequence <400> 37 aaaaccggat ttacgcgtcc 20 <210> 38 <211> 20 <212> DNA <213> Artificial Sequence <400> 38 atatcctcca gctcacgccc 20 <210> 39 <211> 20 <212> DNA <213> Artificial Sequence <400> 39 ggagactgtt tgggctcgaa 20 <210> 40 <211> 20 <212> DNA <213> Artificial Sequence <400> 40 ggtcctgcat ccacgctggg 20 <210> 41 <211> 20 <212> DNA <213> Artificial Sequence <400> 41 ggcaccatag cgactcacca 20 <210> 42 <211> 20 <212> DNA <213> Artificial Sequence <400> 42 cgtcacgatg cattgatccc 20 <210> 43 <211> 20 <212> DNA <213> Artificial Sequence <400> 43 agacgagcag cgctttgccc 20 <210> 44 <211> 20 <212> DNA <213> Artificial Sequence <400> 44 ctttaagaat ggctgtctcc 20 <210> 45 <211> 20 <212> DNA <213> Artificial Sequence <400> 45 cttagcttga atccttcccc 20 <210> 46 <211> 20 <212> DNA <213> Artificial Sequence <400> 46 atgcctgggc aacgaaaacc 20 <210> 47 <211> 20 <212> DNA <213> Artificial Sequence <400> 47 ggcaagacta tggaaccgaa 20 <210> 48 <211> 20 <212> DNA <213> Artificial Sequence <400> 48 ggtaggagct ggccaagaca 20 <210> 49 <211> 20 <212> DNA <213> Artificial Sequence <400> 49 gggagcctcg cgagtcacca 20 <210> 50 <211> 20 <212> DNA <213> Artificial Sequence <400> 50 ggcctcgtcg gggacttcac 20 <210> 51 <211> 20 <212> DNA <213> Artificial Sequence <400> 51 tctttgtcta cgtttccacc 20 <210> 52 <211> 20 <212> DNA <213> Artificial Sequence <400> 52 accagccgcg atcaatcata 20 <210> 53 <211> 20 <212> DNA <213> Artificial Sequence <400> 53 ggttagctgc aatacgcgga 20 <210> 54 <211> 19 <212> DNA <213> Artificial Sequence <400> 54 agaaaccagc cgcgatcaa 19 <210> 55 <211> 20 <212> DNA <213> Artificial Sequence <400> 55 gctgcaatac gcggatacag 20 <210> 56 <211> 20 <212> DNA <213> Artificial Sequence <400> 56 accgcttagt catgttgggg 20 <210> 57 <211> 22 <212> DNA <213> Artificial Sequence <400> 57 cgcatcaaga taagtgcaca aa 22 <210> 58 <211> 20 <212> DNA <213> Artificial Sequence <400> 58 cattcccgct tcaaagcaca 20 <210> 59 <211> 22 <212> DNA <213> Artificial Sequence <400> 59 caggtcccaa gaagaactga ag 22 <210> 60 <211> 20 <212> DNA <213> Artificial Sequence <400> 60 ttcacattcc cgtagtcggc 20 <210> 61 <211> 22 <212> DNA <213> Artificial Sequence <400> 61 aggtcccaag aagaactgaa gt 22 <210> 62 <211> 20 <212> DNA <213> Artificial Sequence <400> 62 agccgacaaa tctgaaccga 20 <210> 63 <211> 20 <212> DNA <213> Artificial Sequence <400> 63 acaaacgacg acatgggtgt 20 <210> 64 <211> 19 <212> DNA <213> Artificial Sequence <400> 64 gctgggggtg caagtgatt 19 <210> 65 <211> 20 <212> DNA <213> Artificial Sequence <400> 65 ccagttccag aggtgagctg 20 <210> 66 <211> 21 <212> DNA <213> Artificial Sequence <400> 66 aggggcatat aagagcaagc a 21 <210> 67 <211> 20 <212> DNA <213> Artificial Sequence <400> 67 acacaaggga gccaagtgag 20 <210> 68 <211> 20 <212> DNA <213> Artificial Sequence <400> 68 cgccaggcta gggttgaaaa 20 <210> 69 <211> 20 <212> DNA <213> Artificial Sequence <400> 69 tacaaacaag cagcccaggg 20 <210> 70 <211> 20 <212> DNA <213> Artificial Sequence <400> 70 gctaccaaga cttgcacgag 20 <210> 71 <211> 20 <212> DNA <213> Artificial Sequence <400> 71 ccccagaatt attagcgccc 20 <210> 72 <211> 20 <212> DNA <213> Artificial Sequence <400> 72 ccaattggga gtggcttgga 20 <210> 73 <211> 20 <212> DNA <213> Artificial Sequence <400> 73 taagggaatg ggcagcagag 20 <210> 74 <211> 20 <212> DNA <213> Artificial Sequence <400> 74 attgttgctg aggcgctaga 20 <210> 75 <211> 20 <212> DNA <213> Artificial Sequence <400> 75 aagtcatgct gtgggcaatg 20 <210> 76 <211> 21 <212> DNA <213> Artificial Sequence <400> 76 gctgtgggca atgtgtcaat g 21 <210> 77 <211> 22 <212> DNA <213> Artificial Sequence <400> 77 tagacaaacg cagtgacttg aa 22 <210> 78 <211> 21 <212> DNA <213> Artificial Sequence <400> 78 agccgaagtt aacggttatg g 21 <210> 79 <211> 20 <212> DNA <213> Artificial Sequence <400> 79 aatcctgtgg gcatgtgcac 20 <210> 80 <211> 21 <212> DNA <213> Artificial Sequence <400> 80 cccttcacag tgctcaaggt a 21 <210> 81 <211> 21 <212> DNA <213> Artificial Sequence <400> 81 caccccttcc tacgttaagc a 21 <210> 82 <211> 20 <212> DNA <213> Artificial Sequence <400> 82 gttcttaccg tggcttgtgc 20 <210> 83 <211> 21 <212> DNA <213> Artificial Sequence <400> 83 gccgaagtta acggttatgg a 21 <210> 84 <211> 21 <212> DNA <213> Artificial Sequence <400> 84 agccgaagtt aacggttatg g 21 <210> 85 <211> 20 <212> DNA <213> Artificial Sequence <400> 85 aatcctgtgg gcatgtgcac 20 <210> 86 <211> 21 <212> DNA <213> Artificial Sequence <400> 86 cttgcaaaag gtgcaaggtg a 21 <210> 87 <211> 20 <212> DNA <213> Artificial Sequence <400> 87 attaaagccg gaggcctcac 20 <210> 88 <211> 20 <212> DNA <213> Artificial Sequence <400> 88 aggattggcc tctcctggaa 20 <210> 89 <211> 20 <212> DNA <213> Artificial Sequence <400> 89 acggtttgag tttgagggct 20 <210> 90 <211> 20 <212> DNA <213> Artificial Sequence <400> 90 aggattggcc tctcctggaa 20 <210> 91 <211> 20 <212> DNA <213> Artificial Sequence <400> 91 acggtttgag tttgagggct 20 <210> 92 <211> 20 <212> DNA <213> Artificial Sequence <400> 92 gactcagaac ggcgtacact 20 <210> 93 <211> 20 <212> DNA <213> Artificial Sequence <400> 93 tttgtatcgc tcgacggcaa 20 <210> 94 <211> 20 <212> DNA <213> Artificial Sequence <400> 94 acaatgtatc aggggcgctt 20 <210> 95 <211> 20 <212> DNA <213> Artificial Sequence <400> 95 tttgtatcgc tcgacggcaa 20 <210> 96 <211> 21 <212> DNA <213> Artificial Sequence <400> 96 tacgaattcg agcgagagac g 21 <210> 97 <211> 20 <212> DNA <213> Artificial Sequence <400> 97 gtatagtgga ccagggtcgg 20 <210> 98 <211> 20 <212> DNA <213> Artificial Sequence <400> 98 gtgcctgctc tcgtccaata 20 <210> 99 <211> 20 <212> DNA <213> Artificial Sequence <400> 99 cggcagctat tacccgtgta 20 <210> 100 <211> 20 <212> DNA <213> Artificial Sequence <400> 100 tgttcggccg tgcaaaatac 20 <210> 101 <211> 20 <212> DNA <213> Artificial Sequence <400> 101 cggagacaca ccattgtgtt 20 <210> 102 <211> 20 <212> DNA <213> Artificial Sequence <400> 102 tgcatgtctc gcttgtgcat 20 <210> 103 <211> 20 <212> DNA <213> Artificial Sequence <400> 103 agcactcagc acttctagcc 20 <210> 104 <211> 20 <212> DNA <213> Artificial Sequence <400> 104 agcactcagc acttctagcc 20 <210> 105 <211> 20 <212> DNA <213> Artificial Sequence <400> 105 catagaacca cccaccacca 20 <210> 106 <211> 23 <212> DNA <213> Artificial Sequence <400> 106 cacttcaaag tggtccttct gtg 23 <210> 107 <211> 21 <212> DNA <213> Artificial Sequence <400> 107 tgtcacccaa caatgcagag a 21 <210> 108 <211> 21 <212> DNA <213> Artificial Sequence <400> 108 actgtcaccc aacaatgcag a 21 <210> 109 <211> 22 <212> DNA <213> Artificial Sequence <400> 109 ttgtctcttt ccacaaatgg ct 22 <210> 110 <211> 22 <212> DNA <213> Artificial Sequence <400> 110 atagcatacc tgccaacaca ct 22 <210> 111 <211> 20 <212> DNA <213> Artificial Sequence <400> 111 agcaagacaa ccagagcatg 20 <210> 112 <211> 20 <212> DNA <213> Artificial Sequence <400> 112 aaacagctgt cagtggagca 20 <210> 113 <211> 23 <212> DNA <213> Artificial Sequence <400> 113 gttagcactt ttgcaatccc tga 23 <210> 114 <211> 20 <212> DNA <213> Artificial Sequence <400> 114 acaccgaaag cagcaagtca 20 <210> 115 <211> 20 <212> DNA <213> Artificial Sequence <400> 115 tttacgacag gccatgacgg 20 <210> 116 <211> 22 <212> DNA <213> Artificial Sequence <400> 116 ctttacaggg ttgctcgcta gt 22 <210> 117 <211> 22 <212> DNA <213> Artificial Sequence <400> 117 taactctctc tctccgtctg cc 22 <210> 118 <211> 22 <212> DNA <213> Artificial Sequence <400> 118 gcgtcagtat aactgtgcaa gc 22 <210> 119 <211> 22 <212> DNA <213> Artificial Sequence <400> 119 aggcattggt aattacaccc ac 22 <210> 120 <211> 22 <212> DNA <213> Artificial Sequence <400> 120 acaagctcga tattcctccg ta 22 <210> 121 <211> 22 <212> DNA <213> Artificial Sequence <400> 121 gaggaccgta cgagtatgga tc 22 <210> 122 <211> 22 <212> DNA <213> Artificial Sequence <400> 122 gagagggcga taggaaaggt at 22 <210> 123 <211> 22 <212> DNA <213> Artificial Sequence <400> 123 ttttatggcc tcgtaaacca ct 22 <210> 124 <211> 22 <212> DNA <213> Artificial Sequence <400> 124 ggatgcatgt aaaagagaag gg 22 <210> 125 <211> 22 <212> DNA <213> Artificial Sequence <400> 125 agccgtcgac attagagaaa ag 22 <210> 126 <211> 22 <212> DNA <213> Artificial Sequence <400> 126 tccatacact caccaacctc ac 22 <210> 127 <211> 22 <212> DNA <213> Artificial Sequence <400> 127 tctcctaaga agccaagtct gg 22 <210> 128 <211> 20 <212> DNA <213> Artificial Sequence <400> 128 aacccactct cttcgggcta 20 <210> 129 <211> 20 <212> DNA <213> Artificial Sequence <400> 129 tctgagttac ggctacccct 20 <210> 130 <211> 20 <212> DNA <213> Artificial Sequence <400> 130 aacccactct cttcgggcta 20 <210> 131 <211> 20 <212> DNA <213> Artificial Sequence <400> 131 gctcttacca ggctgttcca 20 <210> 132 <211> 20 <212> DNA <213> Artificial Sequence <400> 132 gttacggcta cccctttgga 20 <210> 133 <211> 21 <212> DNA <213> Artificial Sequence <400> 133 acaggttatg actgcgcatc c 21 <210> 134 <211> 20 <212> DNA <213> Artificial Sequence <400> 134 tcaccaggga tccgtgtact 20 <210> 135 <211> 20 <212> DNA <213> Artificial Sequence <400> 135 cgcatccact agctctgcat 20 <210> 136 <211> 23 <212> DNA <213> Artificial Sequence <400> 136 tcgagctgtt attgtatcca ctc 23 <210> 137 <211> 20 <212> DNA <213> Artificial Sequence <400> 137 tatgacgact tcgctggtcc 20 <210> 138 <211> 23 <212> DNA <213> Artificial Sequence <400> 138 tcgagctgtt attgtatcca ctc 23 <210> 139 <211> 20 <212> DNA <213> Artificial Sequence <400> 139 tatgacgact tcgctggtcc 20 <210> 140 <211> 23 <212> DNA <213> Artificial Sequence <400> 140 tcgagctgtt attgtatcca ctc 23 <210> 141 <211> 20 <212> DNA <213> Artificial Sequence <400> 141 tatgacgact tcgctggtcc 20 <210> 142 <211> 20 <212> DNA <213> Artificial Sequence <400> 142 ctatgacccg gtgcgacatt 20 <210> 143 <211> 20 <212> DNA <213> Artificial Sequence <400> 143 aacgtcttga tgccttgcag 20 <210> 144 <211> 21 <212> DNA <213> Artificial Sequence <400> 144 ctcacaggag ttggctatgg g 21 <210> 145 <211> 19 <212> DNA <213> Artificial Sequence <400> 145 gtgtgttgct tcgccactt 19 <210> 146 <211> 20 <212> DNA <213> Artificial Sequence <400> 146 agcatcgaca acccatgacc 20 <210> 147 <211> 20 <212> DNA <213> Artificial Sequence <400> 147 tggctatttg gacgtcccag 20 <210> 148 <211> 20 <212> DNA <213> Artificial Sequence <400> 148 tgggcggaca cactgattta 20 <210> 149 <211> 20 <212> DNA <213> Artificial Sequence <400> 149 atccaggcat gaagcgttgt 20 <210> 150 <211> 22 <212> DNA <213> Artificial Sequence <400> 150 caaagagcgt tcgtgttggt ag 22 <210> 151 <211> 24 <212> DNA <213> Artificial Sequence <400> 151 gcttcttttg gtaacgtcga aact 24 <210> 152 <211> 20 <212> DNA <213> Artificial Sequence <400> 152 accagccgcg atcaatcata 20 <210> 153 <211> 21 <212> DNA <213> Artificial Sequence <400> 153 acaatccagc ctgatctcac g 21
Claims
1. A method for efficiently constructing a large genomic fragment deletion mutant, characterized in that: The method for efficiently constructing a large genome deletion mutant deletes a large genome fragment in the zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters. The method first screens out gRNAs with high mutation efficiency, then selects gRNAs with a small efficiency difference for combined microinjection into one-cell stage zebrafish fertilized eggs, and uses CRISPR single-site efficiency evaluation to screen out CRISPR combinations that produce efficient large genome deletions, comprising the following steps: (1) Determine the target sequence for gene knockout in the zebrafish ttn1-ttn2, nppa-nppb and hox gene clusters, and design no less than three specific CRISPR gRNA target sequences at both ends of the gene fragment to be deleted under the condition that the CRISPR PAM region is met; (2) designing amplification primers according to the specific CRISPR gRNA target sequence designed in step (1); (3) Using the gRNA backbone plasmid as a template, using primer T7-gRNA target as a forward primer and gRNA reverse primer to perform PCR amplification to obtain a PCR product; (4) Purifying the PCR product obtained in step (3), and in vitro transcribing to obtain gRNA; (5) microinjecting the gRNA and Cas9 protein or Cas9 mRNA obtained in step (4) into a one-cell stage fertilized egg of zebrafish; (6) extracting genomes from zebrafish eggs at 48 h embryonic stage in step (5), and performing PCR amplification using knockout target detection primers to obtain PCR products; (7) The PCR product obtained in step (6) was subjected to T7E1 restriction enzyme detection and agarose gel electrophoresis in turn, and the grayscale value of the bands in the obtained gel image was detected using the quantitative tool of Image Lab software to obtain the brightness volume of each band a, b and c, and the knockout efficiency was calculated according to the formula indel% = (a+b) / (a+b+c)×100%; (8) selecting no less than three groups of specific CRISPR targets from the specific CRISPR targets at both ends of the gene fragment to be deleted to form the optimal target combination; (9) microinjecting the optimal target combination obtained in step (8) into one-cell stage fertilized eggs of zebrafish; (10) extracting the genome of zebrafish eggs at the 48h embryonic stage in step (9), amplifying the genome by double outer primer PCR and agarose gel electrophoresis, and stably culturing the zebrafish genome large fragment deletion mutant; In step (8), a specific CRISPR target with high and similar T7E1 cleavage activity is selected from the specific CRISPR targets at both ends of the gene fragment to be deleted as the optimal target combination; In step (1), the target sequence is shown in the following table:
2. The method for efficiently constructing a large genomic fragment deletion mutant according to claim 1, characterized in that: In step (6), the sequences of the detection primers are shown in the following table:
3. Application of the method for efficiently constructing large genomic fragment deletion mutants according to claim 1 or 2 in constructing animal models for the treatment and drug screening of diseases caused by the deletion of ttn1-ttn2, nppa-nppb and hox gene clusters.
